MMP-9 polymorphisms are not associated with spontaneous cervical artery dissection

Area of Science:

• Genetics
• Vascular Biology
• Neurology

Background:

• Cervical artery dissection (CAD) is a significant cause of ischemic stroke in young individuals.
• Structural changes in the vascular extracellular matrix are observed in CAD.
• Matrix metalloproteinases (MMPs), particularly MMP-9, are implicated in extracellular matrix degradation and vascular damage.

Purpose of the Study:

• To investigate the potential association between two functional polymorphisms in the matrix metalloproteinase-9 (MMP-9) gene and cervical artery dissection (CAD).
• To determine if specific MMP-9 gene variants are more frequent in patients with CAD compared to healthy controls.

Main Methods:

• Genotyping of 52 patients diagnosed with cervical artery dissection (CAD).
• Analysis of two distinct MMP-9 DNA polymorphisms: a CA repeat and a promoter cytosine to thymidine transition.
• Comparison of allelic frequencies of these polymorphisms with those of 52 healthy control subjects.

Main Results:

• No statistically significant differences were observed in the allelic distribution of the tested MMP-9 polymorphisms between CAD patients and healthy controls.
• The frequency of the CA repeat polymorphism did not differ between the two groups.
• The frequency of the cytosine to thymidine transition polymorphism in the MMP-9 promoter region was also similar in both patient and control cohorts.

Conclusions:

• The studied functional polymorphisms of the matrix metalloproteinase-9 (MMP-9) gene are not associated with cervical artery dissection (CAD).
• These findings suggest that common genetic variations in MMP-9 do not play a significant role in the development of structural alterations in the vascular matrix leading to CAD.
• Further research may be needed to explore other genetic or environmental factors contributing to CAD pathogenesis.